Burak Can
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Burak Can has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Adnan Batman
Division of Endocrinology and Metabolism, Department of Internal Medicine, Acibadem University School of Medicine, Istanbul, Türkiye
1 shared publication - Betul Kalender
Kocaeli University
1 shared publication - Erkan Dervişoğlu
Division of Nephrology, Kocaeli University, Kocaeli, Türkiye
1 shared publication - Metin Ergül
Kocaeli University
1 shared publication - Necmi Eren
Division of Nephrology, Department of Internal Medicine, Kocaeli University Faculty of Medicine, Kocaeli, Türkiye
1 shared publication - Ramazan Azim Okyay
Department of Public Health, University of Health Sciences, Adana Faculty of Medicine, Adana, Türkiye
1 shared publication
Latest Publications
- Open Access
- 30 June 2025
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (2) , 133-139
Relationship between Erectile Dysfunction and Asymmetric Dimethyl Arginine Levels in Patients with End-Stage Renal Disease
Introduction: Asymmetric dimethylarginine is a major inhibitor of nitric oxide synthesis. Erectile dysfunction and chronic kidney disease (CKD) are associated with elevated levels of asymmetric dimethylarginine. This study aimed to examine the effects of ADMA on erectile dysfunction in patients undergoing peritoneal hemodialysis. Methods: A total of 32 peritoneal, 32 hemodialysis patients, and 32 healthy male volunteers were included in the study. Serum asymmetric dimethylarginine levels were measured, and clinical and laboratory parameters were analyzed. The International Index of Erectile Function-5 was used to evaluate sexual function and the Pittsburgh Sleep Quality Index was used to evaluate sleep quality. Depressive symptoms were assessed using the Beck Depression Inventory Scale. Results: Asymmetric dimethylarginine levels differed significantly among the three groups (p
- 30 June 2025
- Published by Kocaeli University in Acta Medica Nicomedia
- Vol. 8 (2) , 133-139
Open AccessRelationship between Erectile Dysfunction and Asymmetric Dimethyl Arginine Levels in Patients with End-Stage Renal Disease
Introduction: Asymmetric dimethylarginine is a major inhibitor of nitric oxide synthesis. Erectile dysfunction and chronic kidney disease (CKD) are associated with elevated levels of asymmetric dimethylarginine. This study aimed to examine the effects of ADMA on erectile dysfunction in patients undergoing peritoneal hemodialysis. Methods: A total of 32 peritoneal, 32 hemodialysis patients, and 32 healthy male volunteers were included in the study. Serum asymmetric dimethylarginine levels were measured, and clinical and laboratory parameters were analyzed. The International Index of Erectile Function-5 was used to evaluate sexual function and the Pittsburgh Sleep Quality Index was used to evaluate sleep quality. Depressive symptoms were assessed using the Beck Depression Inventory Scale. Results: Asymmetric dimethylarginine levels differed significantly among the three groups (p